P
PYXS
Pyxis Oncology, Inc.
1.700
+0.090+5.59%After Hours: 1.600 -0.100 -5.88%18:38 04/10 EDT
OPEN/PREV CLOSE1.610/1.610
TODAY RANGE1.600-1.735
VOL727.62K
MARKET CAP106.81M
52 WEEK RANGE0.8332-5.55
AVG VOL (3M)573.93K
% TURNOVER1.16%
TURNOVER--
P/E (TTM)-1.3268
% RANGE8.39%
EPS(TTM)-1.2813
P/E(FORWARD)-1.3127
P/B1.996
BVPS0.8519
DIVIDEND--
P/S7.69
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP81.97M
SHARES OUTSTANDING62.83M
NEXT EARNINGS05/13-05/18
FREE FLOAT48.22M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·03/28 14:36
Pyxis Oncology (PYXS) Receives a Rating Update from a Top Analyst
Dow Jones·03/24 13:31
Pyxis Oncology Price Target Cut to $8.00/Share From $9.00 by Stifel
Dow Jones·03/24 13:31
Pyxis Oncology Is Maintained at Buy by Stifel
Dow Jones·03/24 11:15
Pyxis Oncology Price Target Maintained With a $7.00/Share by HC Wainwright & Co.
Benzinga·03/24 11:06
HC Wainwright & Co. Reiterates Buy on Pyxis Oncology, Maintains $7 Price Target
TipRanks·03/24 10:56
RBC Capital Remains a Buy on Pyxis Oncology (PYXS)
TipRanks·03/24 10:51
Pyxis Oncology price target lowered to $8 from $9 at Stifel
TipRanks·03/23 11:29
Pyxis Oncology Reports Q4 Results, Advances MICVO Program
Reuters·03/23 11:13
Pyxis Oncology Announces MICVO ADC Clinical Development Program in R/M HNSCC
Benzinga·03/23 11:12
Pyxis Oncology Q4 EPS $(0.29) Beats $(0.33) Estimate, Sales $11.038M